Human Data Indicates Psychedelics Could Reduce Inflammation

Preliminary human data, published in JAMA Psychiatry, suggests classic psychedelics like psilocybin may reduce inflammation and mitochondrial stress. This research indicates a broader physiological impact beyond neurological effects, potentially opening new avenues for treating inflammatory diseases and expanding therapeutic understanding.